NURS 6630 Latest Midterm
Exam Prep 2025-2026
Complete 76 Questions and
Correct Answers// Nurs 6630
Psychopharmacologic
Approaches To Treatment Of
Psychopathology Midterm
Exam Prep
, Question1 1
out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer: Lithium
(Lithobid)
• Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
• Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer: “The patient could benefit from an
pg. 1
, anticonvulsant.”
• Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which
response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected D.
Answer: All of the
above
• Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
• Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer: Changes made to proteins lead to changes in
behavior.
• Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
pg. 2
Exam Prep 2025-2026
Complete 76 Questions and
Correct Answers// Nurs 6630
Psychopharmacologic
Approaches To Treatment Of
Psychopathology Midterm
Exam Prep
, Question1 1
out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer: Lithium
(Lithobid)
• Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
• Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer: “The patient could benefit from an
pg. 1
, anticonvulsant.”
• Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which
response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected D.
Answer: All of the
above
• Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
• Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer: Changes made to proteins lead to changes in
behavior.
• Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
pg. 2
